Wordt geladen...
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is well known as an aggressive disease with poor survival. This has sparked trials of alternate immune-based therapies in MPM. While up to a quarter of MPM patients respond to immune checkpoint inhibitors (ICIs), predicting response remains challengin...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354134/ https://ncbi.nlm.nih.gov/pubmed/32676326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-485 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|